AzTrials
AzTrials

Congestive Heart FailurePhase 1/2NCT00261664

Empowering Elders Through Technology

A Phase 1/2 study testing telehomecare in people with Congestive Heart Failure, run by Robert Wood Johnson Foundation at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Telehomecare is a technology that individuals use in their homes to communicate with health providers electronically. This technology can help them function at a higher level and avoid undesirable hospitalizations by making changes in their everyday behaviors, but research is needed to understand how telehomecare… Read more about this study

Who is it for?
Any age
Conditions the study is for
Congestive Heart Failure
What is being tested?
telehomecare
Type of treatment
Medical device
How many people
290 participants
Where
1 siteUnited States
Study dates
Sep 2003to Jul 2005
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • clinical diagnosis of congestive heart failure
  • must have telephone line in home

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Pennsylvania State University

    University Park, Pennsylvania, 16802

Other trials in United States

About this study

Telehomecare is a technology that individuals use in their homes to communicate with health providers electronically. This technology can help them function at a higher level and avoid undesirable hospitalizations by making changes in their everyday behaviors, but research is needed to understand how telehomecare supports health behavior change and leads to improved health status.

The hypothesis being tested is that the use of an electronic method of monitoring and transmitting health information facilitates patient empowerment, with subsequent effects on the patient's ability to manage her/his treatment regimen more effectively. The study will explore the relationship between telehomecare and acquisition of knowledge, and will show whether changes in knowledge levels translate to changes in behaviors and improved health outcomes. The effects of two different telehomecare systems (nurse-directed vs. patient-directed) on knowledge, self-management, and health status will be compared. A further goal is to illuminate the attitudes of physicians regarding the use of telehomecare in the treatment of their elderly, community dwelling patients.

Results will inform managers and policymakers who are responsible for integrating eHealth mechanisms into chronic disease protocols, funding health care programs, and creating policies that support the use of information technology by all Americans.

Read the detailed description

This study, funded by the Robert Wood Johnson Foundation through its Health e-Technologies Initiative (www.hetinitiative.org) is investigating the impact of telehomecare on health outcomes of persons with heart failure. The study began on September 1, 2003 and ends on February 28, 2006.

This study targets elderly persons with congestive heart failure (CHF), a major health problem affecting more than 4 million Americans. The research hypothesis being tested is that the use of an electronic method of monitoring and transmitting health information facilitates patient empowerment, with subsequent effects on the patient's ability to manage her/his treatment regimen more effectively. The study will explore the linkages between telehomecare and acquisition of knowledge, and will show whether changes in knowledge levels translate to changes in behaviors and improved health outcomes.

The effects of two different telehomecare systems (nurse-directed vs. patient-directed) on knowledge, self-management, and health status will be compared. A further goal is to illuminate the attitudes of physicians regarding the use of telehomecare in the treatment of their elderly, community dwelling patients.

Specific objectives are:

  1. To evaluate the impact of telehomecare on patients' knowledge and self-management of heart failure, and cardiovascular health outcomes;
  2. To compare the effect of two different telehomecare systems on patients' knowledge and self-management of heart failure, and cardiovascular health outcomes;
  3. To investigate how the personal characteristics of older persons influence human-computer interaction and user satisfaction;
  4. To describe and predict the attitudes and intentions of physicians regarding the use of telehomecare applications; and,
  5. To analyze relationships among individual characteristics, information use, self-management of heart-failure and health status.
Being tested
telehomecare
Medical subject headings
Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • telehomecareDevice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-management of heart failure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2005 (estimated)
  2. Study startSep 2003
  3. Study completionJul 2005

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Enrolment
290 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00261664
Sponsor's protocol ID
49150
Status last verified
Jul 2011
First submitted
2 Dec 2005
Last updated
27 Jul 2011
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing telehomecare in people with Congestive Heart Failure, run by Robert Wood Johnson Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-management of heart failure. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in